FDA Approves BRACAnalysis CDx as a Companion Diagnostic for HRR-Mutated Prostate Cancer
BRACAnalysis CDx is the only FDA-approved germline test to identify men with BRCA1 and BRCA2 mutations, a subpopulation of HRR gene mutations.
Read MoreSearch Results for: genetic testing
Sherlock Biosciences Receives EUA for CRISPR SARS-CoV-2 Rapid Diagnostic
Using the company’s namesake method, the covid-19 kit works by programming a CRISPR molecule to detect the genetic signature of the SARS-CoV-2 virus.
Read MoreFDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes Covid-19 in Patients
FDA’s Stephen M. Hahn, MD, and Jeff Shuren, MD, JD, discuss the agency’s first EUA for a covid-19 antigen test.
Read More
AI Identifies Biomarkers of Response to Alzheimer’s Disease Therapy
First reported genomewide search for biomarkers associated with drug response in Alzheimer’s disease offers a template for the use of big data in precision medicine studies.
Read More
Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Read More